BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen JH, Zeng Z, Zhang XX, Zhang Y, Zhang RW, Wang S, Wu CH, Yu M, Liu D, Xi HL, Zhou YX, An YY, Xu XY. Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting. World J Gastroenterol 2017; 23(22): 4072-4079 [PMID: 28652660 DOI: 10.3748/wjg.v23.i22.4072]
URL: https://www.wjgnet.com/1007-9327/full/v23/i22/4072.htm
Number Citing Articles
1
K. V. Kalashnyk, O. V. Riabokon, O. V. Tsarova, Yu. Yu. Riabokon, H. V. Yalova. ЕФЕКТИВНІСТЬ РІЗНИХ СХЕМ ПРОТИВІРУСНОЇ ТЕРАПІЇ ХВОРИХ НА ХРОНІЧНИЙ ГЕПАТИТ С, ІНФІКОВАНИХ 1-м ГЕНОТИПОМ ВІРУСУІнфекційні хвороби 2019; (2): 15 doi: 10.11603/1681-2727.2019.2.10321
2
Nipun Verma, Shreya Singh, Gitesh Sawatkar, Virendra Singh. Sofosbuvir induced steven Johnson Syndrome in a patient with hepatitis C virus‐related cirrhosisHepatology Communications 2018; 2(1): 16 doi: 10.1002/hep4.1126
3
Tyng‐Yuan Jang, Ching‐I Huang, Ming‐Lun Yeh, Po‐Cheng Liang, Pei‐Chien Tsai, Yi‐Hung Lin, Ming‐Yen Hsieh, Nai‐Jen Hou, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Chung‐Feng Huang, Wan‐Long Chuang, Ming‐Lung Yu. Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agentsJournal of Gastroenterology and Hepatology 2020; 35(3): 473 doi: 10.1111/jgh.14835